Page 4 - Eric Benevich News Today

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) – Stock analysts at Cantor Fitzgerald decreased their FY2023 EPS estimates for Neurocrine Biosciences in a research report issued to clients and investors on Tuesday, February 7th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of $3.58 per share for the year, down […]

Operator: Good day, everyone, and welcome to todays Neurocrine Biosciences Reports Fourth Quarter and Year End Results. At this time, all participants are in a listen-only mode.

NBIX earnings call for the period ending June 30, 2022.

Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...

NBIX earnings call for the period ending December 31, 2021.

NBIX earnings call for the period ending September 30, 2021.

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neurocrine Biosciences Inc (NASDAQ: NBIX) Popular Searches Operator Good day, everyone, and welcome to todays Neurocrine Biosciences Reports First Quarter Results. [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.SPONSORED: 10 stocks...

Operator Good day, everyone, and welcome to todays Neurocrine Biosciences Reports Fourth Quarter and Year-End 2020 Results. [Operator Instructions] [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Todd Tushla -- Vice President of Investor Relations Thank you, Clorey. Good afternoon, everyone, and thank you for joining us on our fourth quarter and full year 2020 earnings call. On the call today is Kevin Gorman, our C...